Application of proteomics to the study of Helicobacter pylori and implications for the clinic

References

• Dye KR, Marshall BJ, Frierson HF Jr., et al. Campylobacter pylori colonizing heterotopic gastric tissue in the rectum. Am J Clin Pathol. 1990;93(1):144–147.
   PubMed Web of Science ®Google Scholar
• Atherton JC, Blaser MJ. Coadaptation of Helicobacter pylori and humans: ancient history, modern implications. J Clin Invest. 2009;119(9):2475–2487.
   PubMed Web of Science ®Google Scholar
• Marrelli D, Pedrazzani C, Berardi A, et al. Negative Helicobacter pylori status is associated with poor prognosis in patients with gastric cancer. Cancer. 2009;115(10):2071–2080.
   PubMed Web of Science ®Google Scholar
• Tomb JF, White O, Kerlavage AR, et al. The complete genome sequence of the gastric pathogen Helicobacter pylori. Nature. 1997;388(6642):539–547.
   PubMed Web of Science ®Google Scholar
• Kraft C, Suerbaum S. Mutation and recombination in Helicobacter pylori: mechanisms and role in generating strain diversity. Int J Med Microbiol. 2005;295(5):299–305.
   PubMed Web of Science ®Google Scholar
• Figura N, Trabalzini L, Mini R, et al. Inactivation of Helicobacter pylori cagA gene affects motility. Helicobacter. 2004;9(3):185–193.
   PubMed Web of Science ®Google Scholar
• Falush D, Kraft C, Taylor NS, et al. Recombination and mutation during long-term gastric colonization by Helicobacter pylori: estimates of clock rates, recombination size, and minimal age. Proc Natl Acad Sci USA. 2001;98(26):15056–15061.
   PubMed Web of Science ®Google Scholar
• Suerbaum S, Smith JM, Bapumia K, et al. Free recombination within Helicobacter pylori. Proc Natl Acad Sci USA. 1998;95(21):12619–12624.
   PubMed Web of Science ®Google Scholar
• Baltrus DA, Amieva MR, Covacci A, et al. The complete genome sequence of Helicobacter pylori strain G27. J Bacteriol. 2009;191(1):447–448.
   PubMed Web of Science ®Google Scholar
• Lusini P, Figura N, Valassina M, et al. Increased phospholipase activity in Helicobacter pylori strains isolated from patients with gastric carcinoma. Dig Liver Dis. 2005;37(4):232–239.
   PubMedGoogle Scholar
• Bernardini G, Braconi D, Spreafico A, et al. Post-genomics of bone metabolic dysfunctions and neoplasias. Proteomics. 2012;12(4–5):708–721.
   PubMed Web of Science ®Google Scholar
• Braconi D, Bernardini G, Santucci A. Linking protein oxidation to environmental pollutants: redox proteomic approaches. J Proteomics. 2011;74(11):2324–2337.
   PubMed Web of Science ®Google Scholar
• Braconi D, Bernardini G, Santucci A. Saccharomyces cerevisiae as a model in ecotoxicological studies: a post-genomics perspective. J Proteomics. 2016;137:19–34.
   PubMed Web of Science ®Google Scholar
• Richards AL, Merrill AE, Coon JJ. Proteome sequencing goes deep. Curr Opin Chem Biol. 2015;24:11–17.
   PubMed Web of Science ®Google Scholar
• Greco TM, Cristea IM. Proteomics tracing the footsteps of infectious disease. Mol Cell Proteomics. 2017;16:S5-S14.
   PubMed Web of Science ®Google Scholar
• Figura N, Marcolongo R, Cavallo G, et al. Polysorbate 80 and Helicobacter pylori: a microbiological and ultrastructural study. BMC Microbiol. 2012;12:217.
   PubMed Web of Science ®Google Scholar
• Martini S, D’Addario C, Braconi D, et al. Antibacterial activity of grape extracts on cagA-positive and -negative Helicobacter pylori clinical isolates. J Chemother. 2009;21(5):507–513.
   PubMed Web of Science ®Google Scholar
• Martini S, D’Addario C, Colacevich A, et al. Antimicrobial activity against Helicobacter pylori strains and antioxidant properties of blackberry leaves (Rubus ulmifolius) and isolated compounds. Int J Antimicrob Agents. 2009;34(1):50–59.
   PubMed Web of Science ®Google Scholar
• Lock RA, Cordwell SJ, Coombs GW, et al. Proteome analysis of Helicobacter pylori: major proteins of type strain NCTC 11637. Pathology. 2001;33(3):365–374.
   PubMed Web of Science ®Google Scholar
• Nilsson CL, Larsson T, Gustafsson E, et al. Identification of protein vaccine candidates from Helicobacter pylori using a preparative two-dimensional electrophoretic procedure and mass spectrometry. Anal Chem. 2000;72(9):2148–2153.
   PubMed Web of Science ®Google Scholar
• Haas G, Karaali G, Ebermayer K, et al. Immunoproteomics of Helicobacter pylori infection and relation to gastric disease. Proteomics. 2002;2(3):313–324.
   PubMed Web of Science ®Google Scholar
• Krah A, Miehlke S, Pleissner KP, et al. Identification of candidate antigens for serologic detection of Helicobacter pylori-infected patients with gastric carcinoma. Int J Cancer. 2004;108(3):456–463.
   PubMed Web of Science ®Google Scholar
• Alm RA, Ling LS, Moir DT, et al. Genomic-sequence comparison of two unrelated isolates of the human gastric pathogen Helicobacter pylori. Nature. 1999;397(6715):176–180.
   PubMed Web of Science ®Google Scholar
• Jungblut PR, Bumann D, Haas G, et al. Comparative proteome analysis of Helicobacter pylori. Mol Microbiol. 2000;36(3):710–725.
   PubMed Web of Science ®Google Scholar
• Krah A, Schmidt F, Becher D, et al. Analysis of automatically generated peptide mass fingerprints of cellular proteins and antigens from Helicobacter pylori 26695 separated by two-dimensional electrophoresis. Mol Cell Proteomics. 2003;2(12):1271–1283.
   PubMed Web of Science ®Google Scholar
• Backert S, Kwok T, Schmid M, et al. Subproteomes of soluble and structure-bound Helicobacter pylori proteins analyzed by two-dimensional gel electrophoresis and mass spectrometry. Proteomics. 2005;5(5):1331–1345.
   PubMed Web of Science ®Google Scholar
• Jungblut PR, Schiele F, Zimny-Arndt U, et al. Helicobacter pylori proteomics by 2-DE/MS, 1-DE-LC/MS and functional data mining. Proteomics. 2010;10(2):182–193.
   PubMed Web of Science ®Google Scholar
• Blaser MJ, Perez-Perez GI, Kleanthous H, et al. Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Research. 1995;55(10):2111–2115.
   PubMed Web of Science ®Google Scholar
• Covacci A, Censini S, Bugnoli M, et al. Molecular characterization of the 128-kDa immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer. Proc Natl Acad Sci U S A. 1993;90(12):5791–5795.
   PubMed Web of Science ®Google Scholar
• Crabtree JE, Taylor JD, Wyatt JI, et al. Mucosal IgA recognition of Helicobacter pylori 120 kDa protein, peptic ulceration, and gastric pathology. Lancet. 1991;338(8763):332–335.
   PubMed Web of Science ®Google Scholar
• Tummuru MK, Cover TL, Blaser MJ. Cloning and expression of a high-molecular-mass major antigen of Helicobacter pylori: evidence of linkage to cytotoxin production. Infect Immun. 1799-1809;61(5):1993.
   Google Scholar
• Mini R, Bernardini G, Salzano AM, et al. Comparative proteomics and immunoproteomics of Helicobacter pylori related to different gastric pathologies. J Chromatogr B Analyt Technol Biomed Life Sci. 2006;833(1):63–79.
   PubMed Web of Science ®Google Scholar
• Momynaliev KT, Kashin SV, Chelysheva VV, et al. Functional divergence of Helicobacter pylori related to early gastric cancer. J Proteome Res. 2010;9(1):254–267.
   PubMed Web of Science ®Google Scholar
• Park JW, Song JY, Lee SG, et al. Quantitative analysis of representative proteome components and clustering of Helicobacter pylori clinical strains. Helicobacter. 2006;11(6):533–543.
   PubMed Web of Science ®Google Scholar
• Bumann D, Aksu S, Wendland M, et al. Proteome analysis of secreted proteins of the gastric pathogen Helicobacter pylori. Infect Immun. 2002;70(7):3396–3403.
   PubMed Web of Science ®Google Scholar
• Carlsohn E, Nystrom J, Karlsson H, et al. Characterization of the outer membrane protein profile from disease-related Helicobacter pylori isolates by subcellular fractionation and nano-LC FT-ICR MS analysis. J Proteome Res. 2006;5(11):3197–3204.
   PubMed Web of Science ®Google Scholar
• Chiu KH, Wang LH, Tsai TT, et al. Secretomic analysis of host-pathogen interactions reveals that elongation factor-tu is a potential adherence factor of Helicobacter pylori during pathogenesis. J Proteome Res. 2017;16(1):264–273.
   PubMed Web of Science ®Google Scholar
• Kim N, Weeks DL, Shin JM, et al. Proteins released by Helicobacter pylori in vitro. J Bacteriol. 2002;184(22):6155–6162.
   PubMed Web of Science ®Google Scholar
• Smith TG, Lim JM, Weinberg MV, et al. Direct analysis of the extracellular proteome from two strains of Helicobacter pylori. Proteomics. 2007;7(13):2240–2245.
   PubMed Web of Science ®Google Scholar
• Snider CA, Voss BJ, McDonald WH, et al. Growth phase-dependent composition of the Helicobacter pylori exoproteome. J Proteomics. 2016;130:94–107.
   PubMed Web of Science ®Google Scholar
• Zanotti G, Cendron L. Structural and functional aspects of the Helicobacter pylori secretome. World J Gastroenterol. 2014;20(6):1402–1423.
   PubMed Web of Science ®Google Scholar
• Alm RA, Bina J, Andrews BM, et al. Comparative genomics of Helicobacter pylori: analysis of the outer membrane protein families. Infect Immun. 2000;68(7):4155–4168.
   PubMed Web of Science ®Google Scholar
• Bernardini G, Braconi D, Martelli P, et al. Postgenomics of Neisseria meningitidis for vaccines development. Expert Rev Proteomics. 2007;4(5):667–677.
   PubMed Web of Science ®Google Scholar
• Sabarth N, Lamer S, Zimny-Arndt U, et al. Identification of surface proteins of Helicobacter pylori by selective biotinylation, affinity purification, and two-dimensional gel electrophoresis. J Biol Chem. 2002;277(31):27896–27902.
   PubMed Web of Science ®Google Scholar
• Baik SC, Kim KM, Song SM, et al. Proteomic analysis of the sarcosine-insoluble outer membrane fraction of Helicobacter pylori strain 26695. J Bacteriol. 2004;186(4):949–955.
   PubMed Web of Science ®Google Scholar
• Sabarth N, Hurvitz R, Schmidt M, et al. Identification of Helicobacter pylori surface proteins by selective proteinase K digestion and antibody phage display. J Microbiol Methods. 2005;62(3):345–349.
   PubMed Web of Science ®Google Scholar
• Smiley R, Bailey J, Sethuraman M, et al. Comparative proteomics analysis of sarcosine insoluble outer membrane proteins from clarithromycin resistant and sensitive strains of Helicobacter pylori. J Microbiol. 2013;51(5):612–618.
   PubMed Web of Science ®Google Scholar
• Voss BJ, Gaddy JA, McDonald WH, et al. Analysis of surface-exposed outer membrane proteins in Helicobacter pylori. J Bacteriol. 2014;196(13):2455–2471.
   PubMed Web of Science ®Google Scholar
• Voss BJ, Loh JT, Hill S, et al. Alteration of the Helicobacter pylori membrane proteome in response to changes in environmental salt concentration. Proteomics Clin Appl. 2015;9(11–12):1021–1034.
   PubMed Web of Science ®Google Scholar
• Richter C, Mukherjee O, Ermert D, et al. Moonlighting of Helicobacter pylori catalase protects against complement-mediated killing by utilising the host molecule vitronectin. Sci Rep. 2016;6:24391.
   PubMed Web of Science ®Google Scholar
• Singh B, Su YC, Riesbeck K. Vitronectin in bacterial pathogenesis: a host protein used in complement escape and cellular invasion. Mol Microbiol. 2010;78(3):545–560.
   PubMed Web of Science ®Google Scholar
• Ringner M, Paulsson M, Wadstrom T. Vitronectin binding by Helicobacter pylori. FEMS Microbiol Immunol. 1992;5(4):219–224.
   PubMedGoogle Scholar
• Censini S, Lange C, Xiang Z, et al. cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors. Proc Natl Acad Sci U S A. 1996;93(25):14648–14653.
   PubMed Web of Science ®Google Scholar
• Xiang Z, Censini S, Bayeli PF, et al. Analysis of expression of CagA and VacA virulence factors in 43 strains of Helicobacter pylori reveals that clinical isolates can be divided into two major types and that CagA is not necessary for expression of the vacuolating cytotoxin. Infect Immun. 1995;63(1):94–98.
   PubMed Web of Science ®Google Scholar
• Mueller D, Tegtmeyer N, Brandt S, et al. c-Src and c-Abl kinases control hierarchic phosphorylation and function of the CagA effector protein in Western and East Asian Helicobacter pylori strains. J Clin Invest. 2012;122(4):1553–1566.
   PubMed Web of Science ®Google Scholar
• Selbach M, Moese S, Hauck CR, et al. Src is the kinase of the Helicobacter pylori CagA protein in vitro and in vivo. J Biol Chem. 2002;277(9):6775–6778.
   PubMed Web of Science ®Google Scholar
• Hatakeyama M. Helicobacter pylori CagA and gastric cancer: a paradigm for hit-and-run carcinogenesis. Cell Host Microbe. 2014;15(3):306–316.
   PubMed Web of Science ®Google Scholar
• Backert S, Tegtmeyer N, Composition FW. structure and function of the Helicobacter pylori cag pathogenicity island encoded type IV secretion system. Future Microbiol. 2015;10(6):955–965.
   PubMed Web of Science ®Google Scholar
• Bonvicini F, Baldini L, Pretolani S, et al. Anti-CagA antibodies are associated with atrophic gastritis in a population at high gastric cancer risk: a morphometric study by computerized image analysis. Ital J Gastroenterol Hepatol. 1997;29(5):409–414.
   PubMed Web of Science ®Google Scholar
• Parsonnet J, Friedman GD, Orentreich N, et al. Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection. Gut. 1997;40(3):297–301.
   PubMed Web of Science ®Google Scholar
• Chen SY, Zhang RG, Duan GC. Pathogenic mechanisms of the oncoprotein CagA in H. pylori-induced gastric cancer (Review). Oncol Rep. 2016;36(6):3087–3094.
   PubMed Web of Science ®Google Scholar
• Ali M, Khan AA, Tiwari SK, et al. Association between cag-pathogenicity island in Helicobacter pylori isolates from peptic ulcer, gastric carcinoma, and non-ulcer dyspepsia subjects with histological changes. World J Gastroenterol. 2005;11(43):6815–6822.
   PubMed Web of Science ®Google Scholar
• Kauser F, Khan AA, Hussain MA, et al. The cag pathogenicity island of Helicobacter pylori is disrupted in the majority of patient isolates from different human populations. J Clin Microbiol. 2004;42(11):5302–5308.
   PubMed Web of Science ®Google Scholar
• Backert S, Muller EC, Jungblut PR, et al. Tyrosine phosphorylation patterns and size modification of the Helicobacter pylori CagA protein after translocation into gastric epithelial cells. Proteomics. 2001;1(4):608–617.
   PubMed Web of Science ®Google Scholar
• Backert S, Moese S, Selbach M, et al. Phosphorylation of tyrosine 972 of the Helicobacter pylori CagA protein is essential for induction of a scattering phenotype in gastric epithelial cells. Mol Microbiol. 2001;42(3):631–644.
   PubMed Web of Science ®Google Scholar
• Moese S, Selbach M, Zimny-Arndt U, et al. Identification of a tyrosine-phosphorylated 35 kDa carboxy-terminal fragment (p35CagA) of the Helicobacter pylori CagA protein in phagocytic cells: processing or breakage? Proteomics. 2001;1(4):618–629.
   PubMed Web of Science ®Google Scholar
• Busch B, Weimer R, Woischke C, et al. Helicobacter pylori interferes with leukocyte migration via the outer membrane protein HopQ and via CagA translocation. Int J Med Microbiol. 2015;305(3):355–364.
   PubMed Web of Science ®Google Scholar
• Jimenez-Soto LF, Kutter S, Sewald X, et al. Helicobacter pylori type IV secretion apparatus exploits beta1 integrin in a novel RGD-independent manner. Plos Pathog. 2009;5(12):e1000684.
   PubMed Web of Science ®Google Scholar
• Kwok T, Zabler D, Urman S, et al. Helicobacter exploits integrin for type IV secretion and kinase activation. Nature. 2007;449(7164):862–866.
   PubMed Web of Science ®Google Scholar
• Conradi J, Tegtmeyer N, Wozna M, et al. An RGD helper sequence in CagL of Helicobacter pylori assists in interactions with integrins and injection of CagA. Front Cell Infect Microbiol. 2012;2:70.
   PubMed Web of Science ®Google Scholar
• Ilver D, Arnqvist A, Ogren J, et al. Helicobacter pylori adhesin binding fucosylated histo-blood group antigens revealed by retagging. Science. 1998;279(5349):373–377.
   PubMed Web of Science ®Google Scholar
• Ishijima N, Suzuki M, Ashida H, et al. BabA-mediated adherence is a potentiator of the Helicobacter pylori type IV secretion system activity. J Biol Chem. 2011;286(28):25256–25264.
   PubMed Web of Science ®Google Scholar
• Liechti G, Goldberg JB. Outer membrane biogenesis in Escherichia coli, Neisseria meningitidis, and Helicobacter pylori: paradigm deviations in H. pylori. Front Cell Infect Microbiol. 2012;2:29.
   PubMed Web of Science ®Google Scholar
• Mahdavi J, Sonden B, Hurtig M, et al. Helicobacter pylori SabA adhesin in persistent infection and chronic inflammation. Science. 2002;297(5581):573–578.
   PubMed Web of Science ®Google Scholar
• Javaheri A, Kruse T, Moonens K, et al. Helicobacter pylori adhesin HopQ engages in a virulence-enhancing interaction with human CEACAMs. Nature Microbiology. 2016;2:16189.
   PubMed Web of Science ®Google Scholar
• Higashi H, Tsutsumi R, Muto S, et al. SHP-2 tyrosine phosphatase as an intracellular target of Helicobacter pylori CagA protein. Science. 2002;295(5555):683–686.
   PubMed Web of Science ®Google Scholar
• Hatakeyama M. Oncogenic mechanisms of the Helicobacter pylori CagA protein. Nat Rev Cancer. 2004;4(9):688–694.
   PubMed Web of Science ®Google Scholar
• Zeaiter Z, Huynh HQ, Kanyo R, et al. CagA of Helicobacter pylori alters the expression and cellular distribution of host proteins involved in cell signaling. FEMS Microbiol Lett. 2008;288(2):227–234.
   PubMed Web of Science ®Google Scholar
• Lim JW, Kim H, Kim JM, et al. Cellular stress-related protein expression in Helicobacter pylori-infected gastric epithelial AGS cells. Int J Biochem Cell Biol. 1624-1634;36(8):2004.
   Google Scholar
• Selbach M, Moese S, Backert S, et al. The Helicobacter pylori CagA protein induces tyrosine dephosphorylation of ezrin. Proteomics. 2004;4(10):2961–2968.
   PubMed Web of Science ®Google Scholar
• Ge Z, Zhu YL, Zhong X, et al. Discovering differential protein expression caused by CagA-induced ERK pathway activation in AGS cells using the SELDI-ProteinChip platform. World J Gastroenterol. 2008;14(4):554–562.
   PubMed Web of Science ®Google Scholar
• Glowinski F, Holland C, Thiede B, et al. Analysis of T4SS-induced signaling by H. pylori using quantitative phosphoproteomics. Front Microbiol. 2014;5:356.
   PubMed Web of Science ®Google Scholar
• Holland C, Schmid M, Zimny-Arndt U, et al. Quantitative phosphoproteomics reveals link between Helicobacter pylori infection and RNA splicing modulation in host cells. Proteomics. 2011;11(14):2798–2811.
   PubMed Web of Science ®Google Scholar
• Adada M, Canals D, Hannun YA, et al. Sphingolipid regulation of ezrin, radixin, and moesin proteins family: implications for cell dynamics. Biochim Biophys Acta. 2014;1841(5):727–737.
   PubMed Web of Science ®Google Scholar
• Choi IJ, Kim JS, Kim JM, et al. Effect of inhibition of extracellular signal-regulated kinase 1 and 2 pathway on apoptosis and bcl-2 expression in Helicobacter pylori-infected AGS cells. Infect Immun. 2003;71(2):830–837.
   PubMed Web of Science ®Google Scholar
• Mimuro H, Suzuki T, Nagai S, et al. Helicobacter pylori dampens gut epithelial self-renewal by inhibiting apoptosis, a bacterial strategy to enhance colonization of the stomach. Cell Host Microbe. 2007;2(4):250–263.
   PubMed Web of Science ®Google Scholar
• Buti L, Spooner E, Van Der Veen AG, et al. Helicobacter pylori cytotoxin-associated gene A (CagA) subverts the apoptosis-stimulating protein of p53 (ASPP2) tumor suppressor pathway of the host. Proc Natl Acad Sci U S A. 2011;108(22):9238–9243.
   PubMed Web of Science ®Google Scholar
• Hatakeyama M, Higashi H. Helicobacter pylori CagA: a new paradigm for bacterial carcinogenesis. Cancer Sci. 2005;96(12):835–843.
   PubMed Web of Science ®Google Scholar
• Lind J, Backert S, Pfleiderer K, et al. Systematic analysis of phosphotyrosine antibodies recognizing single phosphorylated EPIYA-motifs in CagA of Western-type Helicobacter pylori strains. Plos One. 2014;9(5):e96488.
   PubMed Web of Science ®Google Scholar
• Lind J, Backert S, Hoffmann R, et al. Systematic analysis of phosphotyrosine antibodies recognizing single phosphorylated EPIYA-motifs in CagA of East Asian-type Helicobacter pylori strains. BMC Microbiol. 2016;16(1):201.
   PubMed Web of Science ®Google Scholar
• Yamaoka Y, Kodama T, Kashima K, et al. Variants of the 3ʹ region of the cagA gene in Helicobacter pylori isolates from patients with different H. pylori-associated diseases. J Clin Microbiol. 1998;36(8):2258–2263.
   PubMed Web of Science ®Google Scholar
• Figura N, Moretti E, Roviello F, et al. cagA structural types of Helicobacter pylori strains isolated from patients with gastric carcinoma and chronic gastritis only. Intern Emerg Med. 2012;7(Suppl 2):S103–105.
   PubMed Web of Science ®Google Scholar
• Yamaoka Y, Osato MS, Sepulveda AR, et al. Molecular epidemiology of Helicobacter pylori: separation of H. pylori from East Asian and non-Asian countries. Epidemiol Infect. 2000;124(1):91–96.
   PubMed Web of Science ®Google Scholar
• Cancer IAfRo. Schistosomes, liver flukes and Helicobacter pylori. In: IARC monographs on the evaluation of the carcinogenic risks to humans.. (Ed.^(Eds) International Agency for Research on Cancer; Lyon, France. 1994. p. 61–177.
   Google Scholar
• Franco AT, Friedman DB, Nagy TA, et al. Delineation of a carcinogenic Helicobacter pylori proteome. Mol Cell Proteomics. 1947-1958;8(8):2009.
   Google Scholar
• Khoder G, Yamaoka Y, Fauchere JL, et al. Proteomic Helicobacter pylori biomarkers discriminating between duodenal ulcer and gastric cancer. J Chromatogr B Analyt Technol Biomed Life Sci. 2009;877(11–12):1193–1199.
   PubMed Web of Science ®Google Scholar
• Repetto O, Zanussi S, Casarotto M, et al. Differential proteomics of Helicobacter pylori associated with autoimmune atrophic gastritis. Mol Med. 2014;20:57–71.
   PubMed Web of Science ®Google Scholar
• Zhang YN, Ding SG, Huang LH, Zhang J, Shi YY, Zhong LJ. Comparative proteome analysis of Helicobacter pylori clinical strains by two-dimensional gel electrophoresis. J Zhejiang Univ Sci B. 2011;12(10):820–827.
   PubMed Web of Science ®Google Scholar
• Karlsson R, Thorell K, Hosseini S, et al. Comparative analysis of two Helicobacter pylori strains using genomics and mass spectrometry-based proteomics. Front Microbiol. 2016;7:1757.
   PubMed Web of Science ®Google Scholar
• Bernardini G, Braconi D, Lusini P, et al. Helicobacter pylori: immunoproteomics related to different pathologies. Expert Rev Proteomics. 2007;4(5):679–689.
   PubMed Web of Science ®Google Scholar
• Lahner E, Bernardini G, Santucci A, et al. Helicobacter pylori immunoproteomics in gastric cancer and gastritis of the carcinoma phenotype. Expert Rev Proteomics. 2010;7(2):239–248.
   PubMed Web of Science ®Google Scholar
• Chuang MH, Wu MS, Lin JT, et al. Proteomic analysis of proteins expressed by Helicobacter pylori under oxidative stress. Proteomics. 2005;5(15):3895–3901.
   PubMed Web of Science ®Google Scholar
• Huang CH, Chiou SH. Proteomic analysis of upregulated proteins in Helicobacter pylori under oxidative stress induced by hydrogen peroxide. Kaohsiung J Med Sci. 2011;27(12):544–553.
   PubMed Web of Science ®Google Scholar
• Huang CH, Chiou SH. Clinical proteomics identifies potential biomarkers in Helicobacter pylori for gastrointestinal diseases. World J Gastroenterol. 2014;20(6):1529–1536.
   PubMed Web of Science ®Google Scholar
• Lin LL, Huang HC, Juan HF. Discovery of biomarkers for gastric cancer: a proteomics approach. J Proteomics. 2012;75(11):3081–3097.
   PubMed Web of Science ®Google Scholar
• Lahner E, Bernardini G, Possenti S, et al. Immunoproteomics of Helicobacter pylori infection in patients with atrophic body gastritis, a predisposing condition for gastric cancer. Int J Med Microbiol. 2011;301(2):125–132.
   PubMed Web of Science ®Google Scholar
• Annibale B, Lahner E, Santucci A, et al. CagA and VacA are immunoblot markers of past Helicobacter pylori infection in atrophic body gastritis. Helicobacter. 2007;12(1):23–30.
   PubMed Web of Science ®Google Scholar
• Kimmel B, Bosserhoff A, Frank R, et al. Identification of immunodominant antigens from Helicobacter pylori and evaluation of their reactivities with sera from patients with different gastroduodenal pathologies. Infect Immun. 2000;68(2):915–920.
   PubMed Web of Science ®Google Scholar
• Lin YF, Wu MS, Chang CC, et al. Comparative immunoproteomics of identification and characterization of virulence factors from Helicobacter pylori related to gastric cancer. Mol Cell Proteomics. 2006;5(8):1484–1496.
   PubMed Web of Science ®Google Scholar
• Yeo M, Park HK, Kim DK, et al. Restoration of heat shock protein70 suppresses gastric mucosal inducible nitric oxide synthase expression induced by Helicobacter pylori. Proteomics. 2004;4(11):3335–3342.
   PubMed Web of Science ®Google Scholar
• Baek HY, Lim JW, Kim H, et al. Oxidative-stress-related proteome changes in Helicobacter pylori-infected human gastric mucosa. Biochem J. 2004;379(Pt 2):291–299.
   PubMed Web of Science ®Google Scholar
• Backert S, Gressmann H, Kwok T, et al. Gene expression and protein profiling of AGS gastric epithelial cells upon infection with Helicobacter pylori. Proteomics. 2005;5(15):3902–3918.
   PubMed Web of Science ®Google Scholar
• Chan CH, Ko CC, Chang JG, et al. Subcellular and functional proteomic analysis of the cellular responses induced by Helicobacter pylori. Mol Cell Proteomics. 2006;5(4):702–713.
   PubMed Web of Science ®Google Scholar
• Ellmark P, Ingvarsson J, Carlsson A, et al. Identification of protein expression signatures associated with Helicobacter pylori infection and gastric adenocarcinoma using recombinant antibody microarrays. Mol Cell Proteomics. 1638-1646;5(9):2006.
   Google Scholar
• Lin LL, Chen CN, Lin WC, et al. Annexin A4: a novel molecular marker for gastric cancer with Helicobacter pylori infection using proteomics approach. Proteomics Clin Appl. 2008;2(4):619–634.
   PubMed Web of Science ®Google Scholar
• Cho SO, Lim JW, Jun JH, et al. Helicobacter pylori in a Korean isolate expressed proteins differentially in human gastric epithelial cells. Dig Dis Sci. 2010;55(6):1550–1564.
   PubMed Web of Science ®Google Scholar
• Lian G, Wei C, Wang D, et al. Protein profiling of Helicobacter pylori-associated gastric cancer. Am J Pathol. 2014;184(5):1343–1354.
   PubMed Web of Science ®Google Scholar
• Chen J, Ge L, Liu A, et al. Identification of pathways related to FAF1/H. pylori-associated gastric carcinogenesis through an integrated approach based on iTRAQ quantification and literature review. J Proteomics. 2016;131:163–176.
   PubMed Web of Science ®Google Scholar
• Zhou J, Wang W, Xie Y, et al. Proteomics-based identification and analysis of proteins associated with Helicobacter pylori in gastric cancer. Plos One. 2016;11(1):e0146521.
   PubMed Web of Science ®Google Scholar
• Mini R, Annibale B, Lahner E, et al. Western blotting of total lysate of Helicobacter pylori in cases of atrophic body gastritis. Clin Chem. 2006;52(2):220–226.
   PubMed Web of Science ®Google Scholar
• N Fg F, Langone F, Vaglio L, et al. Extragastricx manifestations of Helicobacter pylori infection: what is proven and unproven in 2014? In: Buzás GM, Ed. Helicobacter pylori – a worldwide perspective. Bussum, The Netherlands: Bentham Science Publishers; 2014. p. 336–395.
   Google Scholar
• Zhang S, Guo Y, Ma Y, et al. Cytotoxin-associated gene-A-seropositive virulent strains of Helicobacter pylori and atherosclerotic diseases: a systematic review. Chin Med J (Engl). 2008;121(10):946–951.
   PubMed Web of Science ®Google Scholar
• Huang B, Chen Y, Xie Q, et al. CagA-positive Helicobacter pylori strains enhanced coronary atherosclerosis by increasing serum OxLDL and HsCRP in patients with coronary heart disease. Dig Dis Sci. 2011;56(1):109–114.
   PubMed Web of Science ®Google Scholar
• Schottker B, Adamu MA, Weck MN, et al. Helicobacter pylori infection, chronic atrophic gastritis and major cardiovascular events: a population-based cohort study. Atherosclerosis. 2012;220(2):569–574.
   PubMed Web of Science ®Google Scholar
• Franceschi F, Sepulveda AR, Gasbarrini A, et al. Cross-reactivity of anti-CagA antibodies with vascular wall antigens: possible pathogenic link between Helicobacter pylori infection and atherosclerosis. Circulation. 2002;106(4):430–434.
   PubMed Web of Science ®Google Scholar
• Lenzi C, Palazzuoli A, Giordano N, et al. H pylori infection and systemic antibodies to CagA and heat shock protein 60 in patients with coronary heart disease. World J Gastroenterol. 2006;12(48):7815–7820.
   PubMed Web of Science ®Google Scholar
• Shimoda A, Ueda K, Nishiumi S, et al. Exosomes as nanocarriers for systemic delivery of the Helicobacter pylori virulence factor CagA. Sci Rep. 2016;6:18346.
   PubMed Web of Science ®Google Scholar
• Learner AJP, Matthias T. The world incidence and prevalence of autoimmune diseases is increasing. International J Celiac Dis. 2015;3:151–155.
   Google Scholar
• Sorrentino D, Ferraccioli GF, De Vita S, et al. Helicobacter pylori infection and autoimmune processes: an emerging field of study. Ital J Gastroenterol Hepatol. 1998;30(Suppl 3):S310–312.
   PubMed Web of Science ®Google Scholar
• McLeod DS, Cooper DS. The incidence and prevalence of thyroid autoimmunity. Endocrine. 2012;42(2):252–265.
   PubMed Web of Science ®Google Scholar
• Ko GH, Park HB, Shin MK, et al. Monoclonal antibodies against Helicobacter pylori cross-react with human tissue. Helicobacter. 1997;2(4):210–215.
   PubMed Web of Science ®Google Scholar
• Figura N, Di Cairano G, Lore F, et al. The infection by Helicobacter pylori strains expressing CagA is highly prevalent in women with autoimmune thyroid disorders. J Physiol Pharmacol. 1999;50(5):817–826.
   PubMed Web of Science ®Google Scholar
• Shi WJ, Liu W, Zhou XY, et al. Associations of Helicobacter pylori infection and cytotoxin-associated gene A status with autoimmune thyroid diseases: a meta-analysis. Thyroid. 2013;23(10):1294–1300.
   PubMed Web of Science ®Google Scholar
• Figura N, Franceschi F, Santucci A, et al. Extragastric manifestations of Helicobacter pylori infection. Helicobacter. 2010;15(Suppl 1):60–68.
   PubMed Web of Science ®Google Scholar
• Figura N, Marano L, Moretti E, et al. Helicobacter pylori infection and gastric carcinoma: not all the strains and patients are alike. World J Gastrointest Oncol. 2016;8(1):40–54.
   PubMed Web of Science ®Google Scholar
• Allison CC, Kufer TA, Kremmer E, et al. Helicobacter pylori induces MAPK phosphorylation and AP-1 activation via a NOD1-dependent mechanism. Journal of Immunology. 2009;183(12):8099–8109.
   PubMed Web of Science ®Google Scholar
• Turkina MV, Olofsson A, Magnusson KE, et al. Helicobacter pylori vesicles carrying CagA localize in the vicinity of cell-cell contacts and induce histone H1 binding to ATP in epithelial cells. FEMS Microbiol Lett. 2015;362:11.
   Web of Science ®Google Scholar
• Olofsson A, Vallstrom A, Petzold K, et al. Biochemical and functional characterization of Helicobacter pylori vesicles. Mol Microbiol. 2010;77(6):1539–1555.
   PubMed Web of Science ®Google Scholar
• Park SA, Lee HW, Hong MH, et al. Comparative proteomic analysis of Helicobacter pylori strains associated with iron deficiency anemia. Proteomics. 2006;6(4):1319–1328.
   PubMed Web of Science ®Google Scholar
• Mini R, Figura N, D’Ambrosio C, et al. Helicobacter pylori immunoproteomes in case reports of rosacea and chronic urticaria. Proteomics. 2005;5(3):777–787.
   PubMed Web of Science ®Google Scholar
• Braconi D, Bernardini G, Santucci A. Post-genomics and skin inflammation. Mediators Inflamm. 2010;2010: Article ID 364823, p. 12.
   Google Scholar
• Rain JC, Selig L, De Reuse H, et al. The protein-protein interaction map of Helicobacter pylori. Nature. 2001;409(6817):211–215.
   PubMed Web of Science ®Google Scholar
• Figura N, Gennari L, Merlotti D, et al. Prevalence of Helicobacter pylori infection in male patients with osteoporosis and controls. Dig Dis Sci. 2005;50(5):847–852.
   PubMed Web of Science ®Google Scholar
• Kakehasi AM, Rodrigues CB, Carvalho AV, et al. Chronic gastritis and bone mineral density in women. Dig Dis Sci. 2009;54(4):819–824.
   PubMed Web of Science ®Google Scholar